Related Experiment Video

Updated: Jun 12, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

Determinants of coronary artery disease in liver transplant candidates

Alp Aydinalp1, Ilyas Atar, Ugur Bal

  • 1Department of Cardiology, Baskent University Faculty of Medicine, Ankara, Turkey. alpaydinalp@superonline.com

Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
|June 23, 2010
PubMed

Insights

Typical anginal symptoms and elevated low-density lipoprotein cholesterol levels are key indicators of coronary artery disease in liver transplant candidates, aiding preoperative risk assessment.

Area of Science:

  • Cardiology
  • Transplant Surgery
  • Internal Medicine

Background:

  • Liver transplant candidates face risks of cardiovascular complications.
  • Preoperative assessment is crucial for managing these risks.
  • Identifying coronary artery disease determinants is essential.

Purpose of the Study:

  • To determine the factors predicting coronary artery disease (CAD) in liver transplant candidates.
  • To improve preoperative cardiovascular risk stratification.

Main Methods:

  • Retrospective study of 139 liver transplant candidates (>40 years old) undergoing coronary angiography.
  • Exclusion of patients with pre-existing heart conditions.
  • Analysis of symptoms, risk factors, lab tests, and diagnostic imaging.
  • Multivariable logistic regression to identify independent predictors of CAD.

Main Results:

  • Coronary artery disease was found in 9.4% of patients.
  • Higher frequency of diabetes, stable angina, smoking, multiple risk factors, and elevated LDL-C in CAD patients.
  • Electrocardiogram, echocardiography, and stress tests showed limited diagnostic value.
  • Typical angina and LDL-C levels were independent predictors of CAD.

Conclusions:

  • Typical anginal symptoms are significant predictors of CAD in this population.
  • Low-density lipoprotein cholesterol levels are also strong predictors of CAD.
  • These factors can guide preoperative cardiovascular assessment for liver transplant candidates.
Abstract

More Related Videos

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis07:05

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis

Published on: May 17, 2015

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...